1079 related articles for article (PubMed ID: 18834483)
21. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
[TBL] [Abstract][Full Text] [Related]
22. Incidence of skin cancer in 5356 patients following organ transplantation.
Lindelöf B; Sigurgeirsson B; Gäbel H; Stern RS
Br J Dermatol; 2000 Sep; 143(3):513-9. PubMed ID: 10971322
[TBL] [Abstract][Full Text] [Related]
23. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
24. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
25. Narrowband UVB phototherapy for small plaque parapsoriasis.
Aydogan K; Karadogan SK; Tunali S; Adim SB; Ozcelik T
J Eur Acad Dermatol Venereol; 2006 May; 20(5):573-7. PubMed ID: 16684286
[TBL] [Abstract][Full Text] [Related]
26. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
27. Narrow-band ultraviolet B phototherapy in patients with recalcitrant nodular prurigo.
Tamagawa-Mineoka R; Katoh N; Ueda E; Kishimoto S
J Dermatol; 2007 Oct; 34(10):691-5. PubMed ID: 17908139
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
29. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
30. Skin disease and malignancy. An epidemiological study.
Sigurgeirsson B
Acta Derm Venereol Suppl (Stockh); 1992; 178():1-110. PubMed ID: 1288038
[TBL] [Abstract][Full Text] [Related]
31. NB-UVB (311-312 nm)-induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy.
Friedland R; David M; Feinmesser M; Barzilai A; Hodak E
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1158-62. PubMed ID: 21790796
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
Tahir R; Mujtaba G
J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
34. UVB doses in maintenance psoriasis phototherapy versus solar UVB exposure.
Schothorst AA; Slaper H; Schouten R; Suurmond D
Photodermatol; 1985 Aug; 2(4):213-20. PubMed ID: 4059077
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
[TBL] [Abstract][Full Text] [Related]
36. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
Granstein RD; Morison WL; Kripke ML
Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
[TBL] [Abstract][Full Text] [Related]
37. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
Harnes DK; Thune P
Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
[TBL] [Abstract][Full Text] [Related]
38. Rate of acute adverse events for narrow-band UVB and Psoralen-UVA phototherapy.
Martin JA; Laube S; Edwards C; Gambles B; Anstey AV
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):68-72. PubMed ID: 17523927
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
40. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
